BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38094297)

  • 1. Purinergic P2X7 receptor expression increases in leukocytes from intra-abdominal septic patients.
    Martínez-Banaclocha H; García-Palenciano C; Martínez-Alarcón L; Amores-Iniesta J; Martín-Sánchez F; Ercole GA; González-Lisorge A; Fernández-Pacheco J; Martínez-Gil P; Padilla-Rodríguez J; Baroja-Mazo A; Pelegrín P; Martínez-García JJ
    Front Immunol; 2023; 14():1297249. PubMed ID: 38094297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity.
    García-Villalba J; Hurtado-Navarro L; Peñín-Franch A; Molina-López C; Martínez-Alarcón L; Angosto-Bazarra D; Baroja-Mazo A; Pelegrin P
    Front Immunol; 2022; 13():894470. PubMed ID: 35663992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD14 release induced by P2X7 receptor restricts inflammation and increases survival during sepsis.
    Alarcón-Vila C; Baroja-Mazo A; de Torre-Minguela C; Martínez CM; Martínez-García JJ; Martínez-Banaclocha H; García-Palenciano C; Pelegrin P
    Elife; 2020 Nov; 9():. PubMed ID: 33135636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
    Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
    J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.
    Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V
    Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2X7 Receptor Signaling Contributes to Sepsis-Associated Brain Dysfunction.
    Savio LEB; Andrade MGJ; de Andrade Mello P; Santana PT; Moreira-Souza ACA; Kolling J; Longoni A; Feldbrügge L; Wu Y; Wyse ATS; Robson SC; Coutinho-Silva R
    Mol Neurobiol; 2017 Oct; 54(8):6459-6470. PubMed ID: 27730511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2X7 receptor deletion attenuates oxidative stress and liver damage in sepsis.
    Larrouyet-Sarto ML; Tamura AS; Alves VS; Santana PT; Ciarlini-Magalhães R; Rangel TP; Siebert C; Hartwig JR; Dos Santos TM; Wyse ATS; Takiya CM; Coutinho-Silva R; Savio LEB
    Purinergic Signal; 2020 Dec; 16(4):561-572. PubMed ID: 33090332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complex P2X7 receptor/inflammasome in perivascular fat tissue of heavy smokers.
    Rossi C; Santini E; Chiarugi M; Salvati A; Comassi M; Vitolo E; Madec S; Solini A
    Eur J Clin Invest; 2014; 44(3):295-302. PubMed ID: 24372548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2X4 receptor as a modulator in the function of P2X receptor in CD4+ T cells from peripheral blood and adipose tissue.
    Ruiz-Rodríguez VM; Cortes-García JD; de Jesús Briones-Espinoza M; Rodríguez-Varela E; Vega-Cárdenas M; Gómez-Otero A; García-Hernández MH; Portales-Pérez DP
    Mol Immunol; 2019 Aug; 112():369-377. PubMed ID: 31279218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsis.
    Martínez-García JJ; Martínez-Banaclocha H; Angosto-Bazarra D; de Torre-Minguela C; Baroja-Mazo A; Alarcón-Vila C; Martínez-Alarcón L; Amores-Iniesta J; Martín-Sánchez F; Ercole GA; Martínez CM; González-Lisorge A; Fernández-Pacheco J; Martínez-Gil P; Adriouch S; Koch-Nolte F; Luján J; Acosta-Villegas F; Parrilla P; García-Palenciano C; Pelegrin P
    Nat Commun; 2019 Jun; 10(1):2711. PubMed ID: 31221993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of P2X7 receptor expression in peripheral lymphocytes and immune profile from patients with indeterminate form of Chagas disease.
    Souza VD; Dos Santos JT; Cabral FL; Barbisan F; Azevedo MI; Dias Carli LF; de Avila Botton S; Dos Santos Jaques JA; Rosa Leal DB
    Microb Pathog; 2017 Mar; 104():32-38. PubMed ID: 28062289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
    Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
    J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in the P2X7 receptor, and differential expression of Toll-like receptor-mediated cytokines and defensins, in a Canadian Indigenous group.
    Semple C; Choi KG; Kroeker A; Denechezhe L; Orr P; Mookherjee N; Larcombe L
    Sci Rep; 2019 Oct; 9(1):14204. PubMed ID: 31578370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The P2X7 Receptor Contributes to the Development of the Exacerbated Inflammatory Response Associated with Sepsis.
    Santana PT; Benjamim CF; Martinez CG; Kurtenbach E; Takiya CM; Coutinho-Silva R
    J Innate Immun; 2015; 7(4):417-27. PubMed ID: 25675986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of purinergic P2X
    Lajdova I; Oksa A; Horvathova M; Spustova V
    J Physiol Pharmacol; 2017 Oct; 68(5):779-785. PubMed ID: 29375053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of various inducers on the expression of P2X7 receptor in human peripheral blood mononuclear cells.
    Zhang XJ; Zheng GG; Ma XT; Lin YM; Song YH; Wu KF
    Sheng Li Xue Bao; 2005 Apr; 57(2):193-8. PubMed ID: 15830104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2X4 receptor regulates P2X7 receptor-dependent IL-1β and IL-18 release in mouse bone marrow-derived dendritic cells.
    Sakaki H; Fujiwaki T; Tsukimoto M; Kawano A; Harada H; Kojima S
    Biochem Biophys Res Commun; 2013 Mar; 432(3):406-11. PubMed ID: 23428419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of endothelial NO synthase and P2X7 receptor modification mediates the cholinergic control of ATP-induced interleukin-1β release by mononuclear phagocytes.
    Richter K; Asci N; Singh VK; Yakoob SH; Meixner M; Zakrzewicz A; Liese J; Hecker A; Wilker S; Stumpf S; Schlüter KD; Rohde M; Gödecke A; Padberg W; Manzini I; Schmalzing G; Grau V
    Front Immunol; 2023; 14():1140592. PubMed ID: 36969210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy.
    Khalafalla MG; Woods LT; Camden JM; Khan AA; Limesand KH; Petris MJ; Erb L; Weisman GA
    J Biol Chem; 2017 Oct; 292(40):16626-16637. PubMed ID: 28798231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered donor P2X7 activity in human leukocytes correlates with P2RX7 genotype but does not affect the development of graft-versus-host disease in humanised mice.
    Adhikary SR; Geraghty NJ; Cuthbertson P; Sluyter R; Watson D
    Purinergic Signal; 2019 Jun; 15(2):177-192. PubMed ID: 31001750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.